Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Psychopharmacotherapy and dry eye syndrome (CROSBI ID 670013)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija

Bakija, Ivana ; Kaštelan, Snježana ; Bogadi, Marija ; Pili, Kristijan ; Filipčić, Igor Psychopharmacotherapy and dry eye syndrome // Book of abstracts of the 2018 OCCSEE & EAOO Conference. 2018. str. 150-150

Podaci o odgovornosti

Bakija, Ivana ; Kaštelan, Snježana ; Bogadi, Marija ; Pili, Kristijan ; Filipčić, Igor

engleski

Psychopharmacotherapy and dry eye syndrome

Educational topic Dry eye syndrome (DES) is one of the most common ocular morbidities and often results in significant eye discomfort, visual disturbances and potential damage to the corneal surface. It is a very common eye condition which can be caused by different mechanisms, affects quality of life of large number of population and represents an important and common public health problem. Many systemic drugs have been associated with ocular and visual side effects that require ophthalmological assessment. Furthermore it is known that some drugs used in psychiatry may cause ocular drying through reduction of tear film production. Discussion DES is well-recognized adverse side effect of many topical and systemic medications including psychiatric drugs. In psychiatry, patients with depression, schizophrenia and other psychotic disorders, posttraumatic stress disorders (PTSD) or bipolar disorders who are taking antidepressants, antipsychotics, lithium carbonate and sodium valproate frequently experience dry eye symptoms. Many ocular side effects of psychiatric medications can only be identified with a complete ophthalmological examination which is frequently ignored by psychiatrists during the psychiatric treatment. There is an increasing awareness that incidence of ocular side effects rises rapidly with the use of polypharmacy that is very often seen in psychiatric patients and thus this fact should not be neglected. Conclusions Psychiatrists, ophthalmologists and patients need to be aware and prepared for possible medication- induced adverse effect such as dry eye during the psychiatric treatment. In order to reduce the incidence of side effects of applied medications clinicians should try to use the lowest possible dose to achieve the desired therapeutic effect. Consequently further studies regarding the potential mechanisms of psychiatric medications on the tear film function as well as ocular surface alteration are needed.

psychopharmacotherapy ; dry eye syndrome

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

150-150.

2018.

nije evidentirano

objavljeno

Podaci o matičnoj publikaciji

Book of abstracts of the 2018 OCCSEE & EAOO Conference

Podaci o skupu

2018 Optometry Conference of Central and South-Eastern Europe (OCCSEE) & European Academy of Optometry and Optics (EAOO)

poster

11.05.2018-13.05.2018

Pula, Hrvatska

Povezanost rada

Kliničke medicinske znanosti